The award, presented at the 9th Protein Summit in Lille, France, comes just days after Calysta officially opened its market introduction facility to produce FeedKind in Teesside, England.
Dr. Alan Shaw, Calysta President and CEO, said: “We’re extremely pleased to have achieved this global accolade that recognises our proprietary technology as a game-changing innovation.
“With FeedKind, Calysta has an exciting opportunity to offer traceable and safe protein that will sustainably help feed the world for decades to come.”
Calysta has partnered with Cargill for production of FeedKind protein in North America and entered into a global joint marketing agreement. A global production facility is expected to open in the United States within two years.
Member of the judging panel, Dr. Anne Wagner, Corporate Research & Development Director at Tereos, said: “We felt that we needed to award an innovation which is truly disruptive both from a technological point of view and also one that identifies alternative sources of protein to meet the protein demands of a growing population”.
Located in the Netherlands, Bridge2Food is a research group that supports international organisations and businesses in the food and animal feed industries in relation to protein ingredients